Overview
Gregory Griffin is a Pediatric Hematologist Oncology provider in Wilmington, Delaware. Dr. Griffin is rated as an Experienced provider by MediFind in the treatment of Retinoblastoma. His top areas of expertise are Retinoblastoma and Immune Thrombocytopenic Purpura (ITP).
His clinical research consists of co-authoring 6 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Retinoblastoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- PPO
Locations
Additional Areas of Focus
Dr. Griffin has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Ann Leahey is a Pediatric Hematologist Oncology provider in Philadelphia, Pennsylvania. Dr. Leahey is rated as an Advanced provider by MediFind in the treatment of Retinoblastoma. Her top areas of expertise are Retinoblastoma, Pineocytoma, Rathke Cleft Cyst, and Pineoblastoma.
Anna Meadows is a Pediatric Hematologist Oncology specialist and a Pediatrics provider in Philadelphia, Pennsylvania. Dr. Meadows is rated as an Advanced provider by MediFind in the treatment of Retinoblastoma. Her top areas of expertise are Retinoblastoma, Gliomatosis Cerebri, Pineocytoma, and Rathke Cleft Cyst.
Garrett Brodeur is a Pediatric Hematologist Oncology provider in Philadelphia, Pennsylvania. Dr. Brodeur is rated as a Distinguished provider by MediFind in the treatment of Retinoblastoma. His top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Bannayan-Riley-Ruvalcaba Syndrome, and Retinoblastoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers